AMAT — Applied Materials, Inc.

The post-earnings reaction was negative: AMAT sold off from $739.67 to the $482 area even though Q3 FY26 revenue/EPS beat consensus and Q4 guidance ($10.25B revenue, $4.02 non-GAAP EPS) came in well above Street estimates. Sell-side sentiment remains bullish, with a Buy consensus and an average target near $673, but short-term market sentiment is cautious given the stock's still-rich ~38x forward multiple and broader tech valuation compression.

Revenue has inflected sharply higher: Q3 FY26 revenue of $9.115B was up 24.8% YoY, and Q4 guidance of $10.25B implies roughly 50.7% YoY growth against a weak Q4 FY25 base. Operating margins are expanding in sequence, from ~30.6% in Q3 FY25 to ~33.7% in Q3 FY26, with non-GAAP gross margin above 50%. The one blemish is Q2 FY26 free cash flow, where OCF was only $845M against net income of $2.806B, but Q3 OCF rebounded to $3.037B, suggesting working-capital noise rather than a structural profit-quality problem. This is an acceleration, not a one-quarter blip.

Expensive. As of 2026-08-27, TTM P/E is 41.3x, forward P/E is roughly 37.6x using the consensus next-FY EPS estimate of $12.82, and P/S is 12.4x versus the 5-year average of 5.0x. P/B is 14.9x, and the dividend yield is just 0.4%. The PEG ratio of 1.08 looks reasonable only if you assume sustained high-20s/30s EPS growth; against a more normalized growth rate, the stock is still priced for a very strong AI-capital-equipment cycle.

At $482.36, the market is pricing in continued AI-driven semiconductor equipment growth rather than a cyclical downturn. If Q4 FY26 guidance annualizes to an EPS run-rate near $16, the current multiple becomes less extreme, but that assumes the supercycle holds into FY2027. The stock is trading well below the $673 average analyst target, so it is discounting some of the Street's optimism, but it is not priced as a value stock—it is priced for earnings to keep delivering.

As of 2026-08-27, RSI(14) is 41.67, price is 6.1% below the 20-day SMA, 12.9% below the 50-day SMA, and 20.5% above the 200-day SMA. That is a short-term downtrend within a longer-term uptrend, not an oversold bounce setup. A reclaim of the 20-day/50-day zone would signal stabilization; the 200-day SMA is the major support level to watch.

• Hyperscaler AI capex is the dominant demand driver; any pause or digestion period in AI infrastructure spending would hit AMAT hard.
• Semiconductor capital equipment is inherently cyclical; memory/logic fab utilization and clean-room capacity constraints drive near-term order timing.
• Export controls and China policy remain an overhang; China revenue concentration can be reset by regulation or normalization.
• Interest rates and equity multiple compression disproportionately affect high-beta, high-multiple technology names like AMAT.
• The structural shift to GAA transistors, HBM, and advanced packaging is raising content per wafer and extending the upcycle.

• Q4 FY26 earnings in mid-November 2026: whether actual revenue and gross margin deliver on the $10.25B revenue and 50%+ gross margin guidance.
• 2027 capex guidance from TSMC, Samsung, and Intel at industry conferences/investor days, plus updates on AMAT's expected >70% packaging revenue growth in 2026.
• Any clarity or relaxation on China export-control rules, and continued advanced packaging/HBM order announcements.

• Valuation re-rating risk: at 41x TTM P/E and 12.4x sales versus 5-year averages of 19.5x and 5.0x, multiple compression could offset otherwise strong earnings growth.
• China/geopolitical restrictions: tightening export controls or a faster-than-expected normalization of China revenue could dent growth.
• Cyclical demand air-pocket: AI capex is lumpy; if hyperscalers pause or memory customers pull forward orders, the growth inflection could reverse quickly.
• Customer concentration and competition: reliance on TSMC, Samsung, and Intel, plus competitive pressure in etch/deposition/advanced packaging.

Applied Materials is a high-quality semiconductor-equipment leader with accelerating revenue, expanding margins, and a clean balance sheet, and it is well positioned for the AI-driven advanced-packaging/GAA cycle. But after the huge run and even after the pullback, the stock is still expensive on absolute and historical valuation measures, so it is more of an accumulate-on-weakness franchise than a clear bargain today.

I applied a 35x forward P/E to an estimated FY2027 GAAP EPS of roughly $15.30, derived from the Q4 FY26 earnings run-rate with ~15% revenue growth and operating leverage. The 35x multiple is a premium to AMAT's 19.5x 5-year average P/E, justified by its high ROIC, margins, and AI exposure, but it is below the current ~38x forward multiple to leave room for cyclical risk.